Functional drug screenings at a higher throughput
MaxWell Biosystems Completes CHF 4 million Series A Financing Round
18-Dec-2020 -
MaxWell Biosystems AG, a spin-off from ETH Zürich founded in 2016 announced the closing of a CHF 4 million Series A financing round to further industrialize and scale-up the production of their consumables, so called multiwell high-density microelectrode array (HD-MEA) plates. Such scale-up will ...
cell imaging systems
drug screening
microelectrode arrays
+2